A detailed history of Scotia Capital Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Scotia Capital Inc. holds 1,214,197 shares of JNJ stock, worth $188 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
1,214,197
Previous 1,231,874 1.43%
Holding current value
$188 Million
Previous $180 Million 9.29%
% of portfolio
1.1%
Previous 1.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$145.48 - $167.38 $2.57 Million - $2.96 Million
-17,677 Reduced 1.43%
1,214,197 $197 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $1.2 Million - $1.31 Million
8,333 Added 0.68%
1,231,874 $180 Million
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $6.29 Million - $6.59 Million
40,507 Added 3.42%
1,223,541 $194 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $1.78 Million - $1.94 Million
12,200 Added 1.04%
1,183,034 $185 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $3.34 Million - $3.74 Million
-21,431 Reduced 1.8%
1,170,834 $182 Million
Q2 2023

Aug 03, 2023

BUY
$154.35 - $166.11 $7.56 Million - $8.14 Million
48,985 Added 4.28%
1,192,265 $197 Million
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $5.76 Million - $6.87 Million
38,133 Added 3.45%
1,143,280 $177 Million
Q4 2022

Feb 09, 2023

BUY
$160.2 - $179.79 $2.79 Million - $3.14 Million
17,440 Added 1.6%
1,105,147 $195 Million
Q3 2022

Nov 10, 2022

BUY
$161.33 - $179.52 $7.03 Million - $7.82 Million
43,570 Added 4.17%
1,087,707 $178 Million
Q2 2022

Aug 05, 2022

SELL
$168.19 - $186.01 $1.57 Million - $1.73 Million
-9,313 Reduced 0.88%
1,044,137 $185 Million
Q1 2022

May 09, 2022

SELL
$158.14 - $179.59 $3.8 Million - $4.31 Million
-23,998 Reduced 2.23%
1,053,450 $187 Million
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $5.95 Million - $6.61 Million
38,190 Added 3.67%
1,077,448 $184 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $6.69 Million - $7.43 Million
41,399 Added 4.15%
1,039,258 $168 Million
Q2 2021

Aug 12, 2021

BUY
$159.48 - $171.07 $1.21 Million - $1.3 Million
7,576 Added 0.77%
997,859 $164 Million
Q1 2021

May 06, 2021

BUY
$153.07 - $170.48 $5.93 Million - $6.6 Million
38,714 Added 4.07%
990,283 $163 Million
Q4 2020

Feb 11, 2021

BUY
$137.11 - $157.38 $4.83 Million - $5.54 Million
35,227 Added 3.84%
951,569 $150 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $594,368 - $651,316
4,234 Added 0.46%
916,342 $136 Million
Q2 2020

Aug 11, 2020

SELL
$128.81 - $155.51 $220,007 - $265,611
-1,708 Reduced 0.19%
912,108 $129 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $1.33 Million - $1.85 Million
-12,006 Reduced 1.3%
913,816 $120 Million
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $2.8 Million - $3.22 Million
-21,991 Reduced 2.32%
925,822 $135 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $1.96 Million - $2.19 Million
15,411 Added 1.65%
947,813 $123 Million
Q2 2019

Aug 13, 2019

BUY
$131.15 - $144.24 $4.74 Million - $5.22 Million
36,156 Added 4.03%
932,402 $130 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $2.91 Million - $3.24 Million
-23,155 Reduced 2.52%
896,246 $125 Million
Q4 2018

Feb 11, 2019

BUY
$122.84 - $147.84 $1.65 Million - $1.98 Million
13,425 Added 1.48%
919,401 $119 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $9.47 Million - $11.1 Million
77,924 Added 9.41%
905,976 $125 Million
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $1.33 Million - $1.47 Million
11,166 Added 1.37%
828,052 $105 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $12.4 Million - $14.7 Million
99,100 Added 13.81%
816,886 $105 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $903,712 - $989,110
6,887 Added 0.97%
717,786 $100 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $10.2 Million - $10.7 Million
78,859 Added 12.48%
710,899 $92.4 Million
Q2 2017

Aug 15, 2017

BUY
N/A
632,040
632,040 $83.6 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Scotia Capital Inc. Portfolio

Follow Scotia Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.